
Sign up to save your podcasts
Or


ME – also known as Chronic Fatigue Syndrome – has long been one of medicine’s most perplexing conditions. With no definitive diagnostic test and a legacy of scepticism in parts of the medical community, patients have often struggled to be believed. But a surge of new research may finally be shifting the landscape.
In this episode, James Gallagher speaks to Dr Chris Ponting about the latest DecodeME results, which point to a strong genetic component to ME. And Professor Rosemary Boyton outlines the ambition behind the new Rosetta Stone study, designed to build a detailed evidence base of shared biomarkers across ME and Long COVID.
Presenter: James Gallagher
By BBC Radio 44.5
7474 ratings
ME – also known as Chronic Fatigue Syndrome – has long been one of medicine’s most perplexing conditions. With no definitive diagnostic test and a legacy of scepticism in parts of the medical community, patients have often struggled to be believed. But a surge of new research may finally be shifting the landscape.
In this episode, James Gallagher speaks to Dr Chris Ponting about the latest DecodeME results, which point to a strong genetic component to ME. And Professor Rosemary Boyton outlines the ambition behind the new Rosetta Stone study, designed to build a detailed evidence base of shared biomarkers across ME and Long COVID.
Presenter: James Gallagher

7,697 Listeners

880 Listeners

1,048 Listeners

44 Listeners

5,542 Listeners

1,797 Listeners

1,770 Listeners

1,035 Listeners

2,017 Listeners

91 Listeners

261 Listeners

343 Listeners

413 Listeners

413 Listeners

222 Listeners

79 Listeners

477 Listeners

588 Listeners

141 Listeners

3,173 Listeners

732 Listeners

1,003 Listeners

203 Listeners

2,068 Listeners

96 Listeners